Delivery Order SPE2DB22D1017-SPE2DB24FG2LW
Award Date
8/2/24
Potential Completion Date
8/23/24
Potential Value
$2K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,216.11, is for the supply of Envarsus XR 1 MG tablets. This order is placed under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC covers a comprehensive range of...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The award, valued at $1,216.11, is for the supply of Envarsus XR 1 mg tablets, a specialty brand name pharmaceutical medication. This delivery order falls under a larger indefinite delivery contract (IDC) between DLA and...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation for the supply of Envarsus XR 1 mg tablets. The $1,216.11 firm fixed-price contract has an ultimate completion date of August 15, 2024. Amerisourcebergen is a major pharmaceutical distributor that holds several indefinite delivery contracts (IDCs) with federal agencies, including a $999,999,999 IDC with DLA Troop Support Medical for a wide range of medical commodities. This specific...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor. The $1,216.11 firm fixed price delivery order is for the supply of Envarsus XR 1 mg tablets. This contract is not associated with any set-aside designation. The award is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Envarsus XR 1 mg tablets. The $2,577.72 firm-fixed-price contract has an ultimate completion date of April 3, 2025 and is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a broad range of pharmaceutical products and medical supplies...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $2,198.52 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of the pharmaceutical product Envarsus XR 1 mg tablet. This delivery order was issued under an indefinite delivery contract (IDC) with a potential value of $999,999,999.00 awarded by DLA to Amerisourcebergen Drug Corp. The IDC serves as the primary contract vehicle for Amerisourcebergen to...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The $3,230.68 firm fixed price contract is for the delivery of Envarsus XR 4 mg tablets to support military treatment programs and medical facilities. Amerisourcebergen Drug Corp serves as a prime contractor providing a wide range of pharmaceutical products and medical supplies to U.S. government agencies,...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of Envarsus XR 1 mg tablets over a period ending June 7, 2024. The contract, valued at $1,465.68, was awarded by the Defense Logistics Agency (DLA) Troop Support Medical on May 16, 2024. This is a delivery order issued under Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA, which has a ceiling value of up to $999,999,999.00 and runs through December 31, 2025. The...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,071.20, is for the delivery of Envarsus XR 1 mg tablets. It is a firm fixed-price delivery order contract, with an ultimate completion date of April 14, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,687.28 firm fixed-price contract is for the delivery of Envarsus XR 4 mg tablets, a transplant medication, to support military and federal healthcare programs. The contract has an ultimate completion date of August 21, 2023. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC)...